🟢 Painreform is trading 7.55% up on October 20, 2026 with biotech sector up 2.10%

Painreform is trading at $0.79, up 7.55%, with the biotech sector’s 2.10% gain potentially supporting the move.

• No company-specific announcement explaining the October 20 move surfaced in the available search results; the latest company-related items shown were not a new catalyst for this session.
• The move follows consecutive declines in the provided recent closes, but there is no evidence tying those declines to today’s rebound.